You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

bronchodilator

Showing 1 - 25 of 1,356
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Bronchiectasis, Cystic Fibrosis, Primary Ciliary Dyskinesia Trial in Haifa (spirometry, Salbutamol, )

Recruiting
  • Bronchiectasis
  • +4 more
  • spirometry
  • +2 more
  • Haifa, Israel
    Rambam Health Campus
Jun 30, 2023

Pulmonary Disease, Chronic Obstructive Trial in Italy (Bronchodilator Agents)

Terminated
  • Pulmonary Disease, Chronic Obstructive
  • Bronchodilator Agents
  • Bari, BA, Italy
  • +38 more
Dec 23, 2022

Copd Trial in Lille (TRIXEO AEROSPHERE)

Recruiting
  • Copd
  • TRIXEO AEROSPHERE
  • Lille, France
    CHU de Lille
Oct 30, 2023

Reversibility of Bronchial Obstruction in Children Born Preterm

Recruiting
  • Bronchopulmonary Dysplasia
  • +6 more
    • Prague, Czechia
      First faculty of Medicine, Charles university.
    Oct 29, 2023

    Asthma Trial in United States (Bronchodilator)

    Completed
    • Asthma
    • Bronchodilator
    • San Diego, California
    • +8 more
    Dec 1, 2021

    Connect Lung Outcomes With Bronchodilator Use

    Recruiting
    • Chronic Obstructive Pulmonary Disease
    • Asthma
    • Respimetrix flow-volume monitoring device
    • Towson, Maryland
      Pulmonary and Critical Care Associates Of Baltimor
    Sep 17, 2021

    4-12 Years Chinese Controller Naive Asthmatic Children

    Completed
    Has Results
    • Asthma
      • Beijing, Beijing, China
        Capital Institute of Pediatrics
      Sep 27, 2021

      Asthma Trial (Formoterol Fumarate DPI, Mometasone Furoate/Formoterol Fumarate MDI (ex-actuator) without spacer, Mometasone

      Completed
      Has Results
      • Asthma
      • Formoterol Fumarate DPI
      • +5 more
      • (no location specified)
      Feb 7, 2022

      COPD Trial in Kingston (Fentanyl Citrate, Combivent)

      Suspended
      • Chronic Obstructive Pulmonary Disease
      • Kingston, Ontario, Canada
        Respiratory Investigation Unit
      Apr 21, 2022

      COPD Trial (Ipratropium/Levosalbutamol 20/50 mcg Fixed Dose Combination (2 inhalations) via pMDI, Salbutamol 100 mcg Inhaler (2

      Withdrawn
      • Chronic Obstructive Pulmonary Disease
      • Ipratropium/Levosalbutamol 20/50 mcg Fixed Dose Combination (2 inhalations) via pMDI
      • Salbutamol 100 mcg Inhaler (2 inhalations) + Ipratropium 20 mcg Inhalation Aerosol (2 inhalations) Free Combination via MDI
      • (no location specified)
      Sep 3, 2021

      Bronchiectasis Adult Trial in São Paulo (Bronchodilator (Ipratropium and Fenoterol), Placebo)

      Suspended
      • Bronchiectasis Adult
      • Bronchodilator (Ipratropium and Fenoterol)
      • Placebo
      • São Paulo, Brazil
      • +2 more
      Jan 7, 2022

      COPD, Non Small Cell Lung Cancer Trial in Seoul (Vilanterol and Umeclidinium Bromide, Placebo)

      Recruiting
      • Chronic Obstructive Pulmonary Disease
      • Non Small Cell Lung Cancer
      • Vilanterol and Umeclidinium Bromide
      • Placebo
      • Seoul, Korea, Republic of
        Samsung Medical Center
      Apr 1, 2021

      Asthma Trial (Mometasone furoate/formoterol (MF/F) MDI, Fluticasone propionate/salmeterol (F/SC) DPI)

      Completed
      Has Results
      • Asthma
      • Mometasone furoate/formoterol (MF/F) MDI
      • Fluticasone propionate/salmeterol (F/SC) DPI
      • (no location specified)
      Feb 7, 2022

      Asthma Trial in Worldwide (QVM149 150/50/80 µg o.d., QVM149 150/50/160 µg o.d., salmeterol/fluticasone FDC 50/500 µg b.i.d.)

      Completed
      Has Results
      • Asthma
      • QVM149 150/50/80 μg o.d.
      • +2 more
      • Sofia, Bulgaria
      • +11 more
      Sep 30, 2021

      Exercise-induced Bronchospasm Trial in Denver, Englewood, Lakewood (albuterol aerosol by HFA MDI, albuterol aerosol by HFA BOI,

      Completed
      • Exercise-induced Bronchospasm
      • albuterol aerosol by HFA MDI
      • +2 more
      • Denver, Colorado
      • +2 more
      Nov 19, 2021

      COPD, Hypercapnic Trial in Madrid (Control, NIMV group)

      Unknown status
      • Chronic Obstructive Pulmonary Disease
      • Hypercapnic
      • Madrid, Spain
        Hospital Universitario La Paz
      Feb 11, 2021

      COPD (COPD) Trial in Manchester (Glycopyrrolate, Tiotropium, )

      Completed
      • Chronic Obstructive Pulmonary Disease (COPD)
      • Manchester, United Kingdom
        Medicines Evaluation Unit
      Oct 28, 2021

      Bronchiectasis Adult Trial (LABA/LAMA or Placebo inhalation)

      Not yet recruiting
      • Bronchiectasis Adult
      • LABA/LAMA or Placebo inhalation
      • (no location specified)
      Aug 11, 2020

      Wheezing Trial (Salbutamol, Placebo)

      Withdrawn
      • Wheezing
      • (no location specified)
      Jul 16, 2021

      COPD Trial in Changhua (Bronchodilators inhalation)

      Completed
      Has Results
      • Chronic Obstructive Pulmonary Disease
      • Bronchodilators inhalation
      • Changhua, Taiwan, China
        Changhua Christian Hospital
      Jul 8, 2020

      Asthma Trial in Germany, Netherlands, United Kingdom (Treatment A: Matching (morning dose) and QVM149 150/50/80 µg (evening

      Completed
      Has Results
      • Asthma
      • Treatment A: Matching placebo (morning dose) and QVM149 150/50/80 μg (evening dose)
      • +2 more
      • Berlin, Germany
      • +6 more
      Dec 9, 2020

      Copd Trial in Istanbul (Formoterol/Budesonide 12/400 mcg Discair)

      Completed
      • Copd
      • Formoterol/Budesonide 12/400 mcg Discair
      • Istanbul, Turkey
        Yedikule Chest Diseases and Thoracic Surgery Training and Resear
      Jun 12, 2020

      COPD Trial (Tiotropium 18 mcg)

      Completed
      • COPD
      • Tiotropium 18 mcg
      • (no location specified)
      Jun 12, 2020

      es to Hyperinflation and Small Airway Disease in COPD

      Completed
      • COPD
      • mono bronchodilatation
      • dual bronchodilatation
      • Mannheim, Germany
        University Medical Center Mannheim
      Mar 29, 2020

      Pulmonary Arterial Hypertension Trial (Nebulized ipratropium bromide, Nebulized combination ipratropium bromide with salbutamol,

      Withdrawn
      • Pulmonary Arterial Hypertension
      • Nebulized ipratropium bromide
      • +2 more
      • (no location specified)
      Jan 27, 2020